These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 21567096)
1. Various effects of hepatoma-derived growth factor on cell growth, migration and invasion of breast cancer and prostate cancer cells. Guo Z; He Y; Wang S; Zhang A; Zhao P; Gao C; Cao B Oncol Rep; 2011 Aug; 26(2):511-7. PubMed ID: 21567096 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells. Zhang J; Ren H; Yuan P; Lang W; Zhang L; Mao L Cancer Res; 2006 Jan; 66(1):18-23. PubMed ID: 16397209 [TBL] [Abstract][Full Text] [Related]
3. Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition. Chen SC; Kung ML; Hu TH; Chen HY; Wu JC; Kuo HM; Tsai HE; Lin YW; Wen ZH; Liu JK; Yeh MH; Tai MH J Pathol; 2012 Oct; 228(2):158-69. PubMed ID: 22247069 [TBL] [Abstract][Full Text] [Related]
4. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity. Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479 [TBL] [Abstract][Full Text] [Related]
5. Downregulated expression of hepatoma-derived growth factor inhibits migration and invasion of prostate cancer cells by suppressing epithelial-mesenchymal transition and MMP2, MMP9. Yang F; Yu N; Wang H; Zhang C; Zhang Z; Li Y; Li D; Yan L; Liu H; Xu Z PLoS One; 2018; 13(1):e0190725. PubMed ID: 29300772 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of cortactin and SIRT1 expression attenuates migration and invasion of prostate cancer DU145 cells. Nakane K; Fujita Y; Terazawa R; Atsumi Y; Kato T; Nozawa Y; Deguchi T; Ito M Int J Urol; 2012 Jan; 19(1):71-9. PubMed ID: 22050448 [TBL] [Abstract][Full Text] [Related]
7. p53 negatively regulates the hepatoma growth factor HDGF. Sasaki Y; Negishi H; Idogawa M; Yokota I; Koyama R; Kusano M; Suzuki H; Fujita M; Maruyama R; Toyota M; Saito T; Tokino T Cancer Res; 2011 Nov; 71(22):7038-47. PubMed ID: 22006999 [TBL] [Abstract][Full Text] [Related]
8. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer. Das S; Roth CP; Wasson LM; Vishwanatha JK Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178 [TBL] [Abstract][Full Text] [Related]
9. Hepatoma-derived growth factor: A survival-related protein in prostate oncogenesis and a potential target for vitamin K2. Shetty A; Dasari S; Banerjee S; Gheewala T; Zheng G; Chen A; Kajdacsy-Balla A; Bosland MC; Munirathinam G Urol Oncol; 2016 Nov; 34(11):483.e1-483.e8. PubMed ID: 27692835 [TBL] [Abstract][Full Text] [Related]
10. SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells. Wang H; McKnight NC; Zhang T; Lu ML; Balk SP; Yuan X Cancer Res; 2007 Jan; 67(2):528-36. PubMed ID: 17234760 [TBL] [Abstract][Full Text] [Related]
11. [The effects of CXCR4 inhibited by RNA interference on metastasis and invasion of breast cancer cell in vitro]. Zhang SC; Qiao L; Gao H Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):473-5. PubMed ID: 17686306 [TBL] [Abstract][Full Text] [Related]
12. Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells. Han G; Fan B; Zhang Y; Zhou X; Wang Y; Dong H; Wei Y; Sun S; Hu M; Zhang J; Wei L Oncol Rep; 2008 Oct; 20(4):929-39. PubMed ID: 18813837 [TBL] [Abstract][Full Text] [Related]
13. Association of core-binding factor β with the malignant phenotype of prostate and ovarian cancer cells. Davis JN; Rogers D; Adams L; Yong T; Jung JS; Cheng B; Fennell K; Borazanci E; Moustafa YW; Sun A; Shi R; Glass J; Mathis JM; Williams BJ; Meyers S J Cell Physiol; 2010 Nov; 225(3):875-87. PubMed ID: 20607802 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of hepatoma-derived growth factor suppresses the malignant phenotype of U87 human glioma cells. Zhang A; Long W; Guo Z; Guo Z; Cao BB Oncol Rep; 2012 Jul; 28(1):62-8. PubMed ID: 22576797 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of hepatoma-derived growth factor activates the Bad-mediated apoptotic pathway in human cancer cells. Tsang TY; Tang WY; Tsang WP; Co NN; Kong SK; Kwok TT Apoptosis; 2008 Sep; 13(9):1135-47. PubMed ID: 18651222 [TBL] [Abstract][Full Text] [Related]
16. Expression of active plasminogen activator inhibitor-1 reduces cell migration and invasion in breast and gynecological cancer cells. Whitley BR; Palmieri D; Twerdi CD; Church FC Exp Cell Res; 2004 Jun; 296(2):151-62. PubMed ID: 15149846 [TBL] [Abstract][Full Text] [Related]
17. Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1. Fuse M; Nohata N; Kojima S; Sakamoto S; Chiyomaru T; Kawakami K; Enokida H; Nakagawa M; Naya Y; Ichikawa T; Seki N Int J Oncol; 2011 Apr; 38(4):1093-101. PubMed ID: 21258769 [TBL] [Abstract][Full Text] [Related]
18. Down-regulation of Cx43 by retroviral delivery of small interfering RNA promotes an aggressive breast cancer cell phenotype. Shao Q; Wang H; McLachlan E; Veitch GI; Laird DW Cancer Res; 2005 Apr; 65(7):2705-11. PubMed ID: 15805269 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-497 targets hepatoma-derived growth factor and suppresses human prostate cancer cell motility. Wu D; Niu X; Pan H; Zhang Z; Zhou Y; Qu P; Zhou J Mol Med Rep; 2016 Mar; 13(3):2287-92. PubMed ID: 26780929 [TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway. Hsieh MJ; Chen KS; Chiou HL; Hsieh YS Eur J Cell Biol; 2010 Aug; 89(8):598-606. PubMed ID: 20434230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]